{"transactions":[{"id":4633527,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-01T15:57:11.000Z","date":"2026-09-30","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.92,"value":92000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.91 to $0.93 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":1337964,"source":{"system":"sec-edgar","filing":"0001437749-26-031654","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926031654/rdgdoc.xml","form_type":"4"}},{"id":4633526,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-01T15:57:11.000Z","date":"2026-09-29","kind":"purchase","planned":false,"acquired":true,"shares":206813,"price":0.9,"value":186131.7,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.86 to $0.94 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":1237964,"source":{"system":"sec-edgar","filing":"0001437749-26-031654","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926031654/rdgdoc.xml","form_type":"4"}},{"id":4633528,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-01T00:03:57.000Z","date":"2026-09-28","kind":"purchase","planned":false,"acquired":true,"shares":93091,"price":0.84,"value":78196.44,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.82 to $0.85 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":1031151,"source":{"system":"sec-edgar","filing":"0001437749-26-031597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774926031597/rdgdoc.xml","form_type":"4"}},{"id":748746,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:02:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":2983542,"source":{"system":"sec-edgar","filing":"0001193125-26-260245","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260245/ownership.xml","form_type":"4"}},{"id":990540,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-24T21:02:17.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":2.76,"value":414000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.74 to $2.80 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":938060,"source":{"system":"sec-edgar","filing":"0001437749-25-036125","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925036125/rdgdoc.xml","form_type":"4"}},{"id":992952,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-20T22:39:26.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":73385,"price":2.75,"value":201808.75,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.73 to $2.75 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":788060,"source":{"system":"sec-edgar","filing":"0001437749-25-035882","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925035882/rdgdoc.xml","form_type":"4"}},{"id":1033945,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-23T20:06:41.000Z","date":"2025-09-22","kind":"purchase","planned":false,"acquired":true,"shares":7172,"price":2.28,"value":16352.16,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.27 to $2.29 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":714675,"source":{"system":"sec-edgar","filing":"0001437749-25-029725","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029725/rdgdoc.xml","form_type":"4"}},{"id":1035002,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-19","kind":"purchase","planned":false,"acquired":true,"shares":46908,"price":2.29,"value":107419.32,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":707503,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1035001,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-19","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":2.25,"value":900.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":660595,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1035000,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-18","kind":"purchase","planned":false,"acquired":true,"shares":185233,"price":2.24,"value":414921.92,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":660195,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1034999,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-22T20:07:33.000Z","date":"2025-09-18","kind":"purchase","planned":false,"acquired":true,"shares":5400,"price":2.13,"value":11502.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":474962,"source":{"system":"sec-edgar","filing":"0001437749-25-029586","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925029586/rdgdoc.xml","form_type":"4"}},{"id":1143967,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-19T11:32:14.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":32.63,"exercise_date":"2018-03-10","expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0000950170-25-073954","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025073954/ownership.xml","form_type":"4"}},{"id":1143966,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T11:32:14.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":12350,"price":32.63,"value":402980.5,"ownership":{"direct":true},"balance_after":2966667,"source":{"system":"sec-edgar","filing":"0000950170-25-073954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025073954/ownership.xml","form_type":"4"}},{"id":1148205,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1148204,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":9746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.18,"exercise_date":"2016-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":9746},"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1148203,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":2954317,"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1148202,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":9746,"price":25.18,"value":245404.28,"ownership":{"direct":true},"balance_after":2943817,"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1168704,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T20:49:55.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026."}],"balance_after":350000,"derivative":{"exercise_price":1.44,"expiration_date":"2035-04-17","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001437749-25-012554","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925012554/rdgdoc.xml","form_type":"4"}},{"id":1213591,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:06.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037514","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037514/ownership.xml","form_type":"4"}},{"id":1213590,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:06.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":2934071,"source":{"system":"sec-edgar","filing":"0000950170-25-037514","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037514/ownership.xml","form_type":"4"}},{"id":1397145,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-01T20:37:36.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on July 15, 2025."}],"balance_after":600000,"derivative":{"exercise_price":27.42,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-24-030353","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924030353/rdgdoc.xml","form_type":"4"}},{"id":1519528,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:17:23.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":15000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-24-016247","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016247/rdgdoc.xml","form_type":"4"}},{"id":1535604,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-25T13:15:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":117390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":0,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":176085},"source":{"system":"sec-edgar","filing":"0001437749-24-013144","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013144/rdgdoc.xml","form_type":"4"}},{"id":1535603,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Common Stock Warrant","published_at":"2024-04-25T13:15:09.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":117390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":176085,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":176085},"source":{"system":"sec-edgar","filing":"0001437749-24-013144","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013144/rdgdoc.xml","form_type":"4"}},{"id":1535602,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-25T13:15:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":176085,"price":22,"value":3873870.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":469562,"source":{"system":"sec-edgar","filing":"0001437749-24-013144","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924013144/rdgdoc.xml","form_type":"4"}},{"id":1599774,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:15.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3679,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0000950170-24-026615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026615/ownership.xml","form_type":"4"}},{"id":1599773,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T01:00:15.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025."}],"balance_after":2931688,"source":{"system":"sec-edgar","filing":"0000950170-24-026615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026615/ownership.xml","form_type":"4"}},{"id":1749107,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-06T13:00:11.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":78.81,"value":3152400.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.58 to $78.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":140000,"source":{"system":"sec-edgar","filing":"0001209191-23-054442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054442/doc4.xml","form_type":"4"}},{"id":1749106,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-06T13:00:11.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":78.81,"value":788100.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.58 to $78.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-23-054442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054442/doc4.xml","form_type":"4"}},{"id":1798960,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T20:58:25.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":16571,"price":16.65,"value":275907.15,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple open market transactions at prices ranging from $16.57 to $16.70 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":293477,"source":{"system":"sec-edgar","filing":"0001069530-23-000043","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000043/certent-form4.xml","form_type":"4"}},{"id":1798959,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T20:58:25.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":1906,"price":16.8,"value":32020.8,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":276906,"source":{"system":"sec-edgar","filing":"0001069530-23-000043","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000043/certent-form4.xml","form_type":"4"}},{"id":1901285,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:06:37.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":22.34,"value":111700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest over a one (1) year period at a rate of 1/12th per month."}],"balance_after":5000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001069530-23-000023","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000023/certent-form4.xml","form_type":"4"}},{"id":1901284,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-08T20:06:37.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":22.34,"value":446800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest over a three (3) year period at a rate of 1/36th per month."}],"balance_after":25000,"derivative":{"exercise_price":22.34,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001069530-23-000023","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000023/certent-form4.xml","form_type":"4"}},{"id":1964295,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:50.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3257,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001209191-23-017401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017401/doc4.xml","form_type":"4"}},{"id":1964294,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:00:50.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":1523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024."}],"balance_after":2929842,"source":{"system":"sec-edgar","filing":"0001209191-23-017401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017401/doc4.xml","form_type":"4"}},{"id":1963924,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-08T21:07:41.000Z","date":"2023-03-07","kind":"purchase","acquired":true,"shares":77276,"price":25.76,"value":1990629.76,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $25.51 to $26.20 per share.  The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001069530-23-000011","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000011/certent-form4.xml","form_type":"4"}},{"id":1963923,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-08T21:07:41.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":11565,"price":26.13,"value":302193.45,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $25.51 to $26.20 per share.  The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":197724,"source":{"system":"sec-edgar","filing":"0001069530-23-000011","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953023000011/certent-form4.xml","form_type":"4"}},{"id":2174172,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-25T20:20:42.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":36159,"price":23.79,"value":860222.61,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $23.52 to $23.92 per share.  The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":186159,"source":{"system":"sec-edgar","filing":"0001069530-22-000041","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953022000041/certent-form4.xml","form_type":"4"}},{"id":2345772,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T01:03:40.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":5077,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5077,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":5077},"source":{"system":"sec-edgar","filing":"0001209191-22-017348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017348/doc4.xml","form_type":"4"}},{"id":2345771,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T01:03:40.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":2953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023."}],"balance_after":2928319,"source":{"system":"sec-edgar","filing":"0001209191-22-017348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017348/doc4.xml","form_type":"4"}},{"id":2807349,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:01:23.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":5518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5518,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":5518},"source":{"system":"sec-edgar","filing":"0001209191-21-018413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018413/doc4.xml","form_type":"4"}},{"id":2807348,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-06T01:01:23.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022."}],"balance_after":3125366,"source":{"system":"sec-edgar","filing":"0001209191-21-018413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018413/doc4.xml","form_type":"4"}},{"id":2864612,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-13T01:00:34.000Z","date":"2020-08-10","kind":"gift","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a charitable donation to an educational institution."}],"balance_after":3122640,"source":{"system":"sec-edgar","filing":"0001209191-21-010478","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121010478/doc5.xml","form_type":"5"}},{"id":3065216,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-08T00:00:54.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":3140,"price":159.09,"value":499542.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in transactions at prices ranging from $159.01 to $159.17, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":3129140,"source":{"system":"sec-edgar","filing":"0001209191-20-045774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120045774/doc4.xml","form_type":"4"}},{"id":3065215,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-08T00:00:54.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":26860,"price":158.43,"value":4255429.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in transactions at prices ranging from $158.00 to $159.00, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":3132280,"source":{"system":"sec-edgar","filing":"0001209191-20-045774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120045774/doc4.xml","form_type":"4"}},{"id":3065784,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-06T20:36:14.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":38135,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Shares are held in trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3."}],"balance_after":3338135,"source":{"system":"sec-edgar","filing":"0001376339-20-000088","document":"wf-form4_159674615870125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633920000088/wf-form4_159674615870125.xml","form_type":"4"}},{"id":3147988,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-16T01:02:42.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":4673,"price":142.05,"value":663799.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in transactions at prices ranging from $142.00 to $142.30, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":3159140,"source":{"system":"sec-edgar","filing":"0001209191-20-029918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120029918/doc4.xml","form_type":"4"}},{"id":3147987,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-16T01:02:42.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":25327,"price":141.12,"value":3574146.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in transactions at prices ranging from $140.60 to $141.54, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":3163813,"source":{"system":"sec-edgar","filing":"0001209191-20-029918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120029918/doc4.xml","form_type":"4"}},{"id":3242231,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:04:13.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3685,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3685,"derivative":{"exercise_price":114.47,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3685},"source":{"system":"sec-edgar","filing":"0001209191-20-014232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014232/doc4.xml","form_type":"4"}},{"id":3242230,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:04:13.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."}],"balance_after":3189140,"source":{"system":"sec-edgar","filing":"0001209191-20-014232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014232/doc4.xml","form_type":"4"}},{"id":3414352,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T12:00:52.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":3309,"price":87.49,"value":289504.41,"ownership":{"direct":true},"balance_after":3187065,"source":{"system":"sec-edgar","filing":"0001209191-19-049553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119049553/doc4.xml","form_type":"4"}},{"id":3414351,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T12:00:52.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":1691,"price":87.4929,"value":147950.4939,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in transactions at prices ranging from $87.44 to $87.50, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":3183756,"source":{"system":"sec-edgar","filing":"0001209191-19-049553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119049553/doc4.xml","form_type":"4"}},{"id":3433648,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T21:43:18.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":5000,"price":99.3185,"value":496592.5,"ownership":{"direct":true},"balance_after":3182065,"source":{"system":"sec-edgar","filing":"0001209191-19-046851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046851/doc4.xml","form_type":"4"}},{"id":3439317,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-14T20:38:38.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":3700,"price":122.5,"value":453250.0,"ownership":{"direct":true},"balance_after":3177065,"source":{"system":"sec-edgar","filing":"0001209191-19-045929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119045929/doc4.xml","form_type":"4"}},{"id":3440338,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T20:31:15.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":1300,"price":122.5,"value":159250.0,"ownership":{"direct":true},"balance_after":3173365,"source":{"system":"sec-edgar","filing":"0001209191-19-045752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119045752/doc4.xml","form_type":"4"}},{"id":3620927,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T01:01:40.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":3213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":3213,"derivative":{"exercise_price":145.48,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":3213},"source":{"system":"sec-edgar","filing":"0001209191-19-016028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016028/doc4.xml","form_type":"4"}},{"id":3620926,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T01:01:40.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":3172065,"source":{"system":"sec-edgar","filing":"0001209191-19-016028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016028/doc4.xml","form_type":"4"}},{"id":3880891,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-29T22:01:21.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":75000,"price":130.34,"value":9775500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":3170432,"source":{"system":"sec-edgar","filing":"0001209191-18-040091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118040091/doc4.xml","form_type":"4"}},{"id":4009155,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-03-07T23:00:18.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":4820,"derivative":{"exercise_price":71.45,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":4820},"source":{"system":"sec-edgar","filing":"0001209191-18-017786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017786/doc4.xml","form_type":"4"}},{"id":4009154,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T23:00:18.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":3418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock award represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":3245432,"source":{"system":"sec-edgar","filing":"0001209191-18-017786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017786/doc4.xml","form_type":"4"}},{"id":4387329,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-15T01:27:26.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":12350,"derivative":{"exercise_price":32.63,"expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0001209191-17-020680","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020680/doc4.xml","form_type":"4"}},{"id":4387328,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-15T01:27:26.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":3242014,"source":{"system":"sec-edgar","filing":"0001209191-17-020680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020680/doc4.xml","form_type":"4"}}]}